EFFECT OF LONG-TERM DILTIAZEM TREATMENT ON CENTRAL HEMODYNAMICS AND EXERCISE ENDURANCE IN ESSENTIAL-HYPERTENSION

被引:9
作者
LUNDJOHANSEN, P
OMVIK, P
机构
[1] Section of Cardiology, University of Bergen, School of Medicine, Bergen
[2] Section of Cardiology, Medical Department, 5021 Haukeland Hospital, Bergen
关键词
Calcium antagonist; Diltiazem; Endurance; Essential hypertension; Exercise; Extracellular fluid volume; Haemodynamics; Plasma volume;
D O I
10.1093/oxfordjournals.eurheartj.a059748
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of long-term treatment with diltiazem on blood pressure, central haemodynamics and exercise endurance were studied in 16 men (mean age 52 years) with essential hypertension, Intra-arterial pressure and heart rate (HR) were monitored continuously. Cardiac output (CO) was measured by Cardiogreen at rest (supine and sitting) and during 50 W, 100 W and 150 W bicycle exercise. Haemodynamic measurements were repeated after commons bicycling at 150 W for 20 min or until exhaustion. After 1 year on diltiazem (mean daily dose 278 mg) intra-arterial pressure was reduced (P<0.001) in all situations (at rest sitting from 183/108 mmHg to 157/92 mmHg (14%)) due to reduction in total peripheral resistance. HR was reduced at rest (7%) and during exercise (10%). Stroke volume tended to increase while CO was unchanged. Exercise time at constant workload increased by 25%. After a peak level, intra-arterial pressure fell by 3% to 5% (P<0.05,) due to a decrease in total peripheral resistance both before and during diltiazem treatment. Stroke volume and CO remained unchanged during endurance exercise while HR showed a small increase. Thus, there was no reduction in the overall cardiac pump function after long-term diltiazem treatment, and blood flow during exercise was maintained. © 1990 The European Society of Cardiology.
引用
收藏
页码:543 / 551
页数:9
相关论文
共 25 条
[1]  
[Anonymous], 1982, Lancet, V1, P185
[2]   DILTIAZEM - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].
CHAFFMAN, M ;
BROGDEN, RN .
DRUGS, 1985, 29 (05) :387-454
[3]   COMPARISON OF BETA-ADRENOCEPTOR BLOCKERS UNDER MAXIMAL EXERCISE (PINDOLOL V METOPROLOL V ATENOLOL) [J].
ERIKSSEN, J ;
THAULOW, E ;
MUNDAL, R ;
OPSTAD, P ;
NITTERHAUGE, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 :S201-S209
[5]  
GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97
[6]  
Lund-Johansen P., 1967, ACTA MED SCAND, V183, P1
[7]  
LUNDJOHANSEN P, 1970, ACTA MED SCAND, V187, P509
[8]  
LUNDJOHANSEN P, 1983, EUR HEART J, V4, P1
[9]   EXERCISE AND ANTIHYPERTENSIVE THERAPY [J].
LUNDJOHANSEN, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (02) :A98-A107
[10]   CENTRAL HEMODYNAMIC-CHANGES OF CALCIUM-ANTAGONISTS AT REST AND DURING EXERCISE IN ESSENTIAL-HYPERTENSION [J].
LUNDJOHANSEN, P ;
OMVIK, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 :S139-S148